Gene · 1263
Papers1,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphoprotein phosphatase activity positively regulates oligomeric pyrin to trigger inflammasome assembly in phagocytes. | mBio | 2023 | 37787552 | PubTator, text mining | PubMed |
| Therapeutic Potential of Biochanin A in Herpes Simplex Keratitis. | Pharmaceuticals (Basel) | 2023 | 37765049 | PubTator, text mining | PubMed |
| Non-Structural Proteins (Nsp): A Marker for Detection of Human Coronavirus Families. | Pathogens | 2023 | 37764993 | PubTator, text mining | PubMed |
| Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer. | Front Genet | 2023 | 37732318 | PubTator, text mining | PubMed |
| Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia. | Ann Hematol | 2023 | 37702821 | PubTator, text mining | PubMed |
| A new wave of innovations within the DNA damage response. | Signal Transduct Target Ther | 2023 | 37679326 | PubTator, text mining | PubMed |
| PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia. | Blood Cancer J | 2023 | 37679323 | PubTator, text mining | PubMed |
| Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating. | bioRxiv | 2023 | 37662273 | PubTator, text mining | PubMed |
| A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities. | Dis Model Mech | 2023 | 37661832 | PubTator, text mining | PubMed |
| Post-translational modifications and immune responses in liver cancer. | Front Immunol | 2023 | 37609076 | PubTator, text mining | PubMed |
| Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition. | Proc Natl Acad Sci U S A | 2023 | 37603740 | PubTator, text mining | PubMed |
| Kinetics of cardiac troponin and other biomarkers in patients with ST elevation myocardial infarction. | Int J Cardiol Heart Vasc | 2023 | 37602285 | PubTator, text mining | PubMed |
| Editorial: Innovative models of stroke pathology. | Front Neurol | 2023 | 37602269 | PubTator, text mining | PubMed |
| Improved outcome in penile cancer with radiologically enhanced stratification protocol for lymph node staging procedures: a study in 316 inguinal basins with a mean follow-up of 5 years. | BMC Urol | 2023 | 37582745 | PubTator, text mining | PubMed |
| Pentafuhalol-B, a Phlorotannin from Brown Algae, Strongly Inhibits the PLK-1 Overexpression in Cancer Cells as Revealed by Computational Analysis. | Molecules | 2023 | 37570823 | PubTator, text mining | PubMed |
| PLK3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1. | Mol Biol Rep | 2023 | 37568042 | PubTator, text mining | PubMed |
| Distinct molecular profiles of skull bone marrow in health and neurological disorders. | Cell | 2023 | 37562402 | PubTator, text mining | PubMed |
| Candidate biomarkers and persistent transcriptional responses after low and high dose ionizing radiation at high dose rate. | Int J Radiat Biol | 2023 | 37549410 | PubTator, text mining | PubMed |
| Assessment of the Immune Response in Patients with Insulin Resistance, Obesity, and Diabetes to COVID-19 Vaccination. | Vaccines (Basel) | 2023 | 37515018 | PubTator, text mining | PubMed |
| Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease. | J Clin Med | 2023 | 37510939 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1263/papers?page=6